Community-reported Gemzar side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Gemzar Side Effect
Have You dealt with a Gemzar side effect? Share your experience
Review Gemzar Safety Reports submitted to FDA
Total Gemzar reports: 712.Gemzar FDA safety alerts: No.
Reported deaths: 187 Reported hospitalizations: 382.
Take Gemzar Side Effects Survey, Discuss Gemzar with others
FDA Reported Gemzar Side Effects: malignant neoplasm progression, pyrexia, platelet count decreased, oedema peripheral, white blood cell count decreased, thrombocytopenia, interstitial lung disease, nausea, dyspnoea, dyspnoea exertional, haemoglobin decreased.
Gemzar Usage.
If you have questions about Gemzar, you can ask a Health Expert or Ask Patient Community about Gemzar.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
< Previous Showing 201-300 of 712 Next >
Gemzar Side Effects Report #5496467-0Physician from JAPAN reported GEMZAR problem on Oct 12, 2007. Female patient, weighting 114.6 lb, was diagnosed with gallbladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, atrioventricular block complete, disseminated intravascular coagulation, malignant neoplasm progression. GEMZAR dosage: 800 MG, OTHER. Patient died on 07/23/2007.
Gemzar Side Effects Report #5499337-7
GEMZAR problem was reported by a Physician from JAPAN on Oct 16, 2007. Female patient, 71 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration. GEMZAR dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5499338-9
Physician from JAPAN reported GEMZAR problem on Oct 17, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, endocarditis. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5499349-3
GEMZAR problem was reported by a Physician from FRANCE on Oct 19, 2007. Male patient, 72 years of age, weighting 160.9 lb, was diagnosed with bile duct cancer, pain, hypertension and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, vertigo. GEMZAR dosage: 825 MG/M2, OTHER. During the same period patient was treated with SKENAN, ZESTORETIC, KARDEGIC, INEXIUM. Patient recovered.
Gemzar Side Effects Report #5499355-9
Physician from JAPAN reported GEMZAR problem on Oct 16, 2007. Female patient, weighting 100.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pericardial effusion. GEMZAR dosage: 1400 MG, UNK. During the same period patient was treated with ELPLAT, KYTRIL. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5499357-2
GEMZAR problem was reported by a Physician from JAPAN on Oct 17, 2007. Male patient, weighting 121.3 lb, was diagnosed with insomnia, constipation and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, benign prostatic hyperplasia, cataract, dyspnoea, haemoglobin decreased, pericardial effusion, pyrexia, rash, renal failure. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5501602-1
Physician from JAPAN reported GEMZAR problem on Oct 23, 2007. Male patient, 74 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm rupture. GEMZAR dosage: 1000 MG/M2, OTHER. Patient died on 10/14/2007.
Gemzar Side Effects Report #5503137-9
GEMZAR problem was reported by a Physician from CHINA on Oct 19, 2007. Female patient was diagnosed with metastatic gastric cancer, hypertension and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: chest pain, extrasystoles, pulse abnormal, tachycardia. GEMZAR dosage: 750MG/M2 ON DAYS 1 AND 4 EVERY 3 WEEKS. During the same period patient was treated with FLUOROURACIL, ISOSORBIDE MONONITRATE, FELODIPINE, ENALAPRIL MALEATE, METOPROLOL. Patient recovered.
Gemzar Side Effects Report #5503146-X
Physician from JAPAN reported GEMZAR problem on Oct 25, 2007. Female patient, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, cerebral infarction, haemolytic uraemic syndrome. GEMZAR dosage: 1200 MG, OTHER. Patient died on 07/24/2007.
Gemzar Side Effects Report #5443294-6
GEMZAR problem was reported by a Physician from PORTUGAL on Aug 23, 2007. Female patient, 39 years of age, weighting 119.0 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal oedema, oedema peripheral, pleural effusion. GEMZAR dosage: 1500 MG, DAY 1, 8, 15. Patient recovered.
Gemzar Side Effects Report #5446158-7
Consumer or non-health professional from JAPAN reported GEMZAR problem on Aug 28, 2007. Female patient, 78 years of age, weighting 114.6 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, respiratory failure, sepsis. GEMZAR dosage: 800 MG, OTHER. During the same period patient was treated with JUZENTAIHOTO, URSO, GASMOTIN, MUCOSTA. Patient was hospitalized. Patient died on 12/28/2005.
Gemzar Side Effects Report #5447359-4
GEMZAR problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Female patient, weighting 163.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, dyspnoea exertional, white blood cell count decreased. GEMZAR dosage: 1327 MG WKLYX3WKS IV. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5447729-4
Physician from SWITZERLAND reported GEMZAR problem on Aug 28, 2007. Male patient, 69 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: injection site phlebitis. GEMZAR dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5447730-0
GEMZAR problem was reported by a Physician from FRANCE on Sept 03, 2007. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gingival bleeding, thrombocytopenia, tongue haematoma. GEMZAR dosage: 1960 MG, OTHER. During the same period patient was treated with ELOXATIN, ONDANSETRON. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5447742-7
Physician from UNITED STATES reported GEMZAR problem on Aug 29, 2007. Female patient, 45 years of age, weighting 132.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, cardiomyopathy, intestinal obstruction, malignant neoplasm progression. GEMZAR dosage: 1770 MG, UNK. During the same period patient was treated with ALBUTEROL, MIRALAX, REGLAN, COMPAZINE, ALOXI, DECADRON. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5449101-X
GEMZAR problem was reported by a Physician from ITALY on Sept 07, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, constipation, deafness, thrombocytopenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.
Gemzar Side Effects Report #5449109-4
Physician from FRANCE reported GEMZAR problem on Sept 05, 2007. Female patient, 57 years of age, weighting 119.0 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cough, nasopharyngitis, pertussis, pneumocystis jiroveci pneumonia. GEMZAR dosage: unknown. During the same period patient was treated with ELOXATIN, ACETAMINOPHEN, SILOMAT, ATARAX. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5449115-X
GEMZAR problem was reported by a Physician from ITALY on Sept 07, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, malignant neoplasm progression, nausea, neutropenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.
Gemzar Side Effects Report #5449685-1
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Sept 10, 2007. Male patient, 61 years of age, weighting 450.0 lb, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dysuria, haematuria. GEMZAR dosage: 3300MG Q2WKS IV. During the same period patient was treated with ABRAXANE, GLUCOVAN, CYMBALTA, TRAMADOL, DICLOFENAC. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5452786-5
GEMZAR problem was reported by a Physician from ITALY on Sept 07, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, constipation, deafness, thrombocytopenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.
Gemzar Side Effects Report #5452791-9
Physician from JAPAN reported GEMZAR problem on Sept 11, 2007. Male patient, 45 years of age, weighting 139.8 lb, was diagnosed with pancreatic carcinoma stage iv, hepatic function abnormal, pyrexia, prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, febrile neutropenia, malignant neoplasm progression, pancytopenia, pharyngolaryngeal pain, pruritus, pyrexia, rash. GEMZAR dosage: 1776 MG, OTHER. During the same period patient was treated with CISPLATIN, URSOSAN, SULPERAZON, NOVAMIN, GRANISETRON, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/05/2003.
Gemzar Side Effects Report #5456401-6
GEMZAR problem was reported by a Physician from SWEDEN on Sept 04, 2007. Male patient, 70 years of age, was diagnosed with weight control and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: oedema, weight increased. GEMZAR dosage: unknown. During the same period patient was treated with ALVEDON, METOPROLOL TARTRATE, COZAAR, BEHEPAN, FURIX, FRAGMIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5456421-1
Physician from GERMANY reported GEMZAR problem on Sept 08, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: extremity necrosis. GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN, ALIMTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5456447-8
GEMZAR problem was reported by a Physician from JAPAN on Sept 12, 2007. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, jaundice cholestatic. GEMZAR dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5463117-9
Health Professional from UNITED STATES reported GEMZAR problem on Sept 18, 2007. Male patient, weighting 231.3 lb, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, diabetes insipidus, hypernatraemia. GEMZAR dosage: 1500 MG/M2 REDUCED 1125MG/M2 Q 2 WEEKS IV DRIP. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5463348-8
GEMZAR problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, malaise, vomiting, weight decreased. GEMZAR dosage: unknown. During the same period patient was treated with FLUOROURACIL, TAXOTERE, PANCREATIC ENZYMES. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5463350-6
Physician from UNITED STATES reported GEMZAR problem on Sept 17, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea. GEMZAR dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #5469368-1
GEMZAR problem was reported by a Physician from JAPAN on Sept 14, 2007. Female patient, 53 years of age, was diagnosed with bile duct cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, neutrophil count increased, platelet count increased, red blood cell count decreased. GEMZAR dosage: 1200 MG, OTHER. Patient recovered.
Gemzar Side Effects Report #5470645-9
Physician from JAPAN reported GEMZAR problem on Sept 11, 2007. Male patient, 85 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, nausea, pleural effusion. GEMZAR dosage: 1000 MG/M2, OTHER. Patient died on 06/01/2006.
Gemzar Side Effects Report #5402341-8
GEMZAR problem was reported by a Physician from UNITED STATES on July 24, 2007. Female patient, 66 years of age, weighting 142.0 lb, was diagnosed with endometrial cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pulmonary embolism. GEMZAR dosage: 1672 MG, OTHER. Patient recovered.
Gemzar Side Effects Report #5402344-3
Physician from UNITED KINGDOM reported GEMZAR problem on July 25, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, pneumonia, pulmonary fibrosis. GEMZAR dosage: unknown. During the same period patient was treated with AMIODARONE, SALBUTAMOL, LISINOPRIL, ASPIRIN, SIMVASTATIN, CARBOPLATIN. Patient was hospitalized. Patient died on 04/03/2007.
Gemzar Side Effects Report #5407367-6
GEMZAR problem was reported by a Physician from JAPAN on July 25, 2007. Male patient, 55 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anorexia, lung neoplasm, malignant neoplasm progression, stomatitis, white blood cell count decreased. GEMZAR dosage: 1700 MG, OTHER. Patient recovered.
Gemzar Side Effects Report #5407373-1
Physician from SWITZERLAND reported GEMZAR problem on July 31, 2007. Female patient, 48 years of age, was diagnosed with non-small cell lung cancer, metastatic pain, bone pain and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, ascites, aspartate aminotransferase increased, blood bilirubin increased, coma hepatic, confusional state, gallbladder disorder, hepatic failure, jaundice. GEMZAR dosage: 1000 MG/M2, WEEKLY (1/W). During the same period patient was treated with NAPROXEN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 11/10/1997.
Gemzar Side Effects Report #5407374-3
GEMZAR problem was reported by a Physician from JAPAN on July 26, 2007. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer, prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: neuropathy. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with NAVELBINE, ANTIEMETICS AND ANTINAUSEANTS. Patient recovered.
Gemzar Side Effects Report #5407377-9
Physician from JAPAN reported GEMZAR problem on July 26, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pneumonia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5407383-4
GEMZAR problem was reported by a Physician from HUNGARY on July 25, 2007. Female patient, 59 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: urticaria. GEMZAR dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, BETALOC, NUTRIDRINK, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5407399-8
Physician from JAPAN reported GEMZAR problem on Aug 01, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, multi-organ failure, renal failure. GEMZAR dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.
Gemzar Side Effects Report #5407409-8
GEMZAR problem was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, 81 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, atrioventricular block complete, malignant neoplasm progression. GEMZAR dosage: 800 MG, OTHER. Patient died on 07/23/2007.
Gemzar Side Effects Report #5407411-6
Physician from UNITED STATES reported GEMZAR problem on Aug 01, 2007. Female patient, 45 years of age, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pleural effusion, pulmonary oedema, renal failure chronic. GEMZAR dosage: 800 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5409296-0
GEMZAR problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Male patient, 49 years of age, weighting 213.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: nausea. GEMZAR dosage: 2150MG DAY 1, 8,15 IV DRIP. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5409528-9
Pharmacist from UNITED STATES reported GEMZAR problem on Aug 08, 2007. Female patient, 68 years of age, weighting 160.1 lb, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: convulsion, convulsive threshold lowered, underdose. GEMZAR dosage: 1540 MG 1X IV DRIP. During the same period patient was treated with ZOMETA, KEPPRA, FEMARA, ENALAPRIL MALEATE, PRILOSEC. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5409670-2
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 01, 2007. Female patient, 82 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5409674-X
Physician from FRANCE reported GEMZAR problem on Aug 06, 2007. Male patient, 73 years of age, was diagnosed with bladder cancer, arthralgia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dehydration, metabolic disorder, renal failure acute. GEMZAR dosage: unknown. During the same period patient was treated with KAYEXALATE, PARACETAMOL, ANTIINFLAMMATORY, ATARAX, FORLAX, CISPLATIN, ANGIOTENSIN II ANTAGONISTS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5409676-3
GEMZAR problem was reported by a Physician from JAPAN on Aug 01, 2007. Male patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dyscalculia, leukoencephalopathy. GEMZAR dosage: unknown. During the same period patient was treated with RHYTHMY. Patient recovered.
Gemzar Side Effects Report #5409680-5
Physician from JAPAN reported GEMZAR problem on Aug 02, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain, constipation, dyspepsia, prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, pancreatitis, platelet count decreased, pyrexia, white blood cell count decreased. GEMZAR dosage: 1300 MG, OTHER. During the same period patient was treated with FAMOTIDINE, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5411944-6
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 33 years of age, was diagnosed with hodgkin's disease and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. GEMZAR dosage: unknown. During the same period patient was treated with VINORELBINE, DOXORUBICIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5411945-8
Physician from JAPAN reported GEMZAR problem on Aug 01, 2007. Female patient, 66 years of age, weighting 121.3 lb, was diagnosed with pleural mesothelioma malignant, insomnia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: decreased appetite, disease progression, inflammation, interstitial lung disease, pleural effusion, pneumonia. GEMZAR dosage: 1500 MG, OTHER. During the same period patient was treated with CISPLATIN, CARBOPLATIN, LENDORMIN, NAVELBINE. Patient recovered.
Gemzar Side Effects Report #5411947-1
GEMZAR problem was reported by a Physician from JAPAN on Aug 01, 2007. Male patient, 71 years of age, was diagnosed with lung squamous cell carcinoma stage iii and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, radiation pneumonitis. GEMZAR dosage: unknown. During the same period patient was treated with VINORELBINE, THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.
Gemzar Side Effects Report #5411980-X
Pharmacist from UNITED STATES reported GEMZAR problem on Aug 10, 2007. Female patient, 70 years of age, weighting 136.7 lb, was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: deafness bilateral, tinnitus. GEMZAR dosage: 1200 MG/M2 DAYS 1 AND 8 IV DRIP. Patient recovered.
Gemzar Side Effects Report #5411990-2
GEMZAR problem was reported by a Pharmacist from UNITED STATES on Aug 10, 2007. Male patient, 76 years of age, was diagnosed with adenocarcinoma pancreas and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, metastases to liver, mobility decreased. GEMZAR dosage: unknown. During the same period patient was treated with TAXOTERE, OXYCONTIN, ACTOS, AMBIEN, LIPRAM, ENABLEX. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5415253-0
Consumer or non-health professional from SWEDEN reported GEMZAR problem on July 31, 2007. Male patient, 70 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: oedema, weight increased. GEMZAR dosage: unknown. During the same period patient was treated with ALVEDON, METOPROLOL TARTRATE, COZAAR, BEHEPAN, FURIX, FRAGMIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5418081-5
GEMZAR problem was reported by a Physician from SPAIN on Aug 09, 2007. Female patient was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: aspiration. GEMZAR dosage: 2500 MG/M2, UNK. During the same period patient was treated with VINORELBINE. Patient died.
Gemzar Side Effects Report #5418083-9
Physician from JAPAN reported GEMZAR problem on Aug 08, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. GEMZAR dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5418084-0
GEMZAR problem was reported by a Physician from NETHERLANDS on Aug 10, 2007. Female patient was diagnosed with lung neoplasm malignant, metastases to nervous system and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastric perforation, metastases to nervous system. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with CISPLATIN, CORTICOSTEROIDS, BORTEZOMIB. Patient recovered.
Gemzar Side Effects Report #5418090-6
Physician from JAPAN reported GEMZAR problem on Aug 08, 2007. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dyscalculia. GEMZAR dosage: unknown. During the same period patient was treated with RHYTHMY. Patient recovered.
Gemzar Side Effects Report #5422510-0
GEMZAR problem was reported by a Physician from JAPAN on Aug 10, 2007. Male patient, 79 years of age, weighting 123.5 lb, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site extravasation, injection site infection, injection site ulcer. GEMZAR dosage: unknown. During the same period patient was treated with MAGMITT, CISPLATIN. Patient recovered.
Gemzar Side Effects Report #5422512-4
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Aug 14, 2007. Female patient, 69 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: ageusia, constipation, dehydration, diarrhoea, dyspnoea, heart rate increased, nausea, oedema peripheral, pyrexia. GEMZAR dosage: unknown. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5422517-3
GEMZAR problem was reported by a Physician from JAPAN on Aug 09, 2007. Male patient, 61 years of age, weighting 108.0 lb, was diagnosed with prophylaxis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood pressure decreased, c-reactive protein increased, chest x-ray abnormal, febrile neutropenia, haemoglobin decreased, lung infiltration, metastases to central nervous system, platelet count decreased. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with CISPLATIN, ZOFRAN, DEXART. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5422557-4
Physician from UNITED STATES reported GEMZAR problem on Aug 17, 2007. Female patient, 45 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. GEMZAR dosage: 1770 MG, UNK. During the same period patient was treated with ALBUTEROL, MIRALAX, REGLAN, COMPAZINE, ALOXI, DECADRON. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5423558-2
GEMZAR problem was reported by a Health Professional from UNITED STATES on Aug 21, 2007. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile output increased, cholangitis, enterococcal infection, flank pain, fungal infection, international normalised ratio increased, oral intake reduced, perinephric abscess. GEMZAR dosage: 750MG 1XWK X 3WKS IV. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5427433-9
Physician from SPAIN reported GEMZAR problem on Aug 20, 2007. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer, nausea and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: recall phenomenon. GEMZAR dosage: unknown. During the same period patient was treated with GRANISETRON, CODEINE SUL. Patient recovered.
Gemzar Side Effects Report #5427434-0
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 20, 2007. Female patient, 41 years of age, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: recall phenomenon. GEMZAR dosage: 1000 MG/M2, WEEKLY (1/W). During the same period patient was treated with BIPHOSPHONATE, HERCEPTIN, PACLITAXEL. Patient recovered.
Gemzar Side Effects Report #5427436-4
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Aug 17, 2007. Female patient, 44 years of age, weighting 183.0 lb, was diagnosed with endometrial cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, blood potassium decreased, cough, deep vein thrombosis, dyspnoea, face oedema, heart rate increased, hypersensitivity, lung injury. GEMZAR dosage: unknown. During the same period patient was treated with CARBOPLATIN, FOSAMAX. Patient recovered.
Gemzar Side Effects Report #5427443-1
GEMZAR problem was reported by a Physician from JAPAN on Aug 22, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal ulcer haemorrhage. GEMZAR dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5430526-3
Physician from UNITED STATES reported GEMZAR problem on Aug 23, 2007. Female patient, 61 years of age, was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: erythema, oedema, pruritus. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5430548-2
GEMZAR problem was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, continuous haemodiafiltration, diffuse alveolar damage, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, lung infiltration, multi-organ failure. GEMZAR dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.
Gemzar Side Effects Report #5430552-4
Physician from UNITED STATES reported GEMZAR problem on Aug 24, 2007. Female patient was diagnosed with breast cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, dyspnoea exertional, hypoxia, oedema, pleural effusion, pulmonary fibrosis. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with LASIX, LISINOPRIL, METFORMIN, OXYCODONE, PROCRIT, ZANTAC, ADVAIR DISKUS, ALBUTEROL. Patient recovered.
Gemzar Side Effects Report #5440457-0
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 20, 2007. Female patient, 74 years of age, weighting 209.4 lb, was diagnosed with breast cancer metastatic, sleep disorder, gastrooesophageal reflux disease, thrombosis, nausea, nasal ulcer, multiple allergies and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: aortic valve disease mixed, atrial fibrillation, cardiomegaly, international normalised ratio increased, pulmonary oedema, ventricular hypertrophy. GEMZAR dosage: 3000 MG, OTHER. During the same period patient was treated with TAXOL, AMBIEN, NEXIUM, PEPCID, COUMADIN, PROCHLORPERAZINE, DOXYCYCLINE, PHENYLEPHRINE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5440467-3
Physician from FRANCE reported GEMZAR problem on Aug 29, 2007. Female patient, 58 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, malignant neoplasm progression, portal vein thrombosis. GEMZAR dosage: 1250 MG/M2, OTHER. During the same period patient was treated with TAXOL, AVASTIN, PROZAC, LEVOTHYROXINE, ALDACTONE, XANAX. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5376875-9
GEMZAR problem was reported by a Physician from FRANCE on June 26, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer, type 1 diabetes mellitus and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, haemolytic anaemia. GEMZAR dosage: 1250 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, INSULIN MIXTARD, ATACAND, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5376889-9
Physician from JAPAN reported GEMZAR problem on June 19, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: urinary retention. GEMZAR dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5376920-0
GEMZAR problem was reported by a Physician from JAPAN on June 25, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea. GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Gemzar Side Effects Report #5378788-5
Physician from reported GEMZAR problem on June 25, 2007. Male patient, 68 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hepatitis acute. GEMZAR dosage: 1900 MG, OTHER. During the same period patient was treated with ZOMETA, BICALUTAMIDE, MORPHINE, DEXAMETASON. Patient died on 06/15/2007.
Gemzar Side Effects Report #5378857-X
GEMZAR problem was reported by a Physician from JAPAN on June 27, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5378860-X
Physician from JAPAN reported GEMZAR problem on June 26, 2007. Male patient, 54 years of age, weighting 142.2 lb, was diagnosed with bile duct cancer recurrent, insomnia, prophylaxis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, klebsiella bacteraemia. GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with HALCION, MUCOSTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5383221-3
GEMZAR problem was reported by a Physician from JAPAN on June 26, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, flank pain, platelet count decreased, temporal lobe epilepsy, white blood cell count decreased. GEMZAR dosage: 1700 MG, OTHER. During the same period patient was treated with DOGMATYL, MEILAX, NORVASC, CYANOCOBALAMIN, EVIPROSTAT, CARNACULIN. Patient recovered.
Gemzar Side Effects Report #5383224-9
Consumer or non-health professional from PORTUGAL reported GEMZAR problem on June 26, 2007. Female patient, weighting 119.0 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal oedema, oedema peripheral, pleural effusion. GEMZAR dosage: 1500 MG, DAY 1, 8, 15. Patient recovered.
Gemzar Side Effects Report #5383232-8
GEMZAR problem was reported by a Physician from JAPAN on June 28, 2007. Male patient, 61 years of age, weighting 108.0 lb, was diagnosed with prophylaxis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood pressure decreased, bone marrow failure, c-reactive protein increased, chest x-ray abnormal, febrile neutropenia, haemoglobin decreased, metastases to central nervous system, platelet count decreased. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with CISPLATIN, ZOFRAN, DEXART. Patient was hospitalized and became disabled. Patient recovered.
Gemzar Side Effects Report #5383234-1
Physician from JAPAN reported GEMZAR problem on June 29, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain, constipation, dyspepsia, prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. GEMZAR dosage: 1400 MG, OTHER. During the same period patient was treated with GASTER D, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5383270-5
GEMZAR problem was reported by a Physician from JAPAN on July 04, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic artery occlusion, liver abscess, platelet count decreased, skin disorder. GEMZAR dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, MITOMYCIN. Patient died on 12/01/2006.
Gemzar Side Effects Report #5386647-7
Physician from JAPAN reported GEMZAR problem on July 06, 2007. Male patient, 54 years of age, weighting 142.2 lb, was diagnosed with bile duct cancer recurrent, insomnia, prophylaxis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, klebsiella bacteraemia. GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with HALCION, MUCOSTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5386650-7
GEMZAR problem was reported by a Physician from PORTUGAL on July 06, 2007. Female patient, 39 years of age, weighting 119.0 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal oedema, oedema peripheral, pleural effusion. GEMZAR dosage: 1500 MG, DAY 1, 8, 15. Patient recovered.
Gemzar Side Effects Report #5386653-2
Physician from SOUTH AFRICA reported GEMZAR problem on July 05, 2007. Male patient, 74 years of age, weighting 143.3 lb, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, platelet count increased. GEMZAR dosage: 500 MG, WEEKLY (1/W). During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 06/03/2007.
Gemzar Side Effects Report #5388062-9
GEMZAR problem was reported by a Physician from ITALY on July 02, 2007. Female patient, 80 years of age, was diagnosed with ovarian cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, anaemia, cardiac failure, hypertension. GEMZAR dosage: 1400 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5388358-0
Physician from JAPAN reported GEMZAR problem on July 05, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, disseminated intravascular coagulation, jaundice, malignant neoplasm progression, platelet count decreased. GEMZAR dosage: 1550 MG, OTHER. Patient recovered.
Gemzar Side Effects Report #5388359-2
GEMZAR problem was reported by a Physician from JAPAN on July 06, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea. GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Gemzar Side Effects Report #5388361-0
Physician from reported GEMZAR problem on July 05, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, oedema peripheral. GEMZAR dosage: 30 MG/M2, 2/W. Patient recovered.
Gemzar Side Effects Report #5389472-6
GEMZAR problem was reported by a Physician from FRANCE on July 12, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: lymphangitis. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5391072-9
Physician from JAPAN reported GEMZAR problem on July 11, 2007. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: jaundice, malaise, rash, stomatitis, white blood cell count decreased. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with FLUOROURACIL, ISOVORIN, THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.
Gemzar Side Effects Report #5391074-2
GEMZAR problem was reported by a Physician from JAPAN on July 11, 2007. Male patient, 52 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anorexia, pancytopenia, pneumonia. GEMZAR dosage: 1400 MG, WEEKLY (1/W). During the same period patient was treated with PEGASYS. Patient recovered.
Gemzar Side Effects Report #5391077-8
Physician from UNITED STATES reported GEMZAR problem on July 13, 2007. Female patient was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: recall phenomenon. GEMZAR dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #5391080-8
GEMZAR problem was reported by a Physician from SWITZERLAND on July 14, 2007. Female patient, 67 years of age, weighting 141.1 lb, was diagnosed with peritoneal carcinoma, prophylaxis of nausea and vomiting, cardiac disorder, renal failure, sleep disorder and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, bone marrow failure, gamma-glutamyltransferase abnormal, serum ferritin increased. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with NAVOBAN, ASPIRIN, BELOC ZOK, ATORVASTATIN CALCIUM, CALCIUM ACETATE, VALVERDE, PANTOZOL, ZOLPIDEM TARTRATE. Patient recovered.
Gemzar Side Effects Report #5391532-0
Physician from FRANCE reported GEMZAR problem on July 17, 2007. Female patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: neutropenia, rhinitis, toxic skin eruption. GEMZAR dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5392239-6
GEMZAR problem was reported by a Physician from JAPAN on July 12, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain, constipation, dyspepsia, prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, pancreatitis, platelet count decreased, pyrexia, white blood cell count decreased. GEMZAR dosage: unknown. During the same period patient was treated with FAMOTIDINE, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5392247-5
Physician from JAPAN reported GEMZAR problem on July 17, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastric perforation, gastric ulcer, malignant neoplasm progression, respiratory failure, white blood cell count decreased. GEMZAR dosage: unknown. During the same period patient was treated with FLUOROURACIL, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 09/13/2006.
Gemzar Side Effects Report #5393815-7
GEMZAR problem was reported by a Health Professional from UNITED STATES on July 20, 2007. Male patient, weighting 142.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood culture positive, cholangitis, sepsis, stent occlusion. GEMZAR dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5400681-X
Physician from JAPAN reported GEMZAR problem on July 18, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cerebral infarction,